Matches in Wikidata for { <http://www.wikidata.org/entity/Q74279997> ?p ?o ?g. }
Showing items 1 to 37 of
37
with 100 items per page.
- Q74279997 description "clinical trial" @default.
- Q74279997 description "ensayu clínicu" @default.
- Q74279997 description "klinisch onderzoek" @default.
- Q74279997 description "клінічне випробування" @default.
- Q74279997 name "This Study Will Evaluate the Efficacy, Safety, and Pharmacokinetics of the Port Delivery System With Ranibizumab (PDS) in Participants With Diabetic Macular Edema (DME) Compared With Intravitreal Ranibizumab" @default.
- Q74279997 name "This Study Will Evaluate the Efficacy, Safety, and Pharmacokinetics of the Port Delivery System With Ranibizumab (PDS) in Participants With Diabetic Macular Edema (DME) Compared With Intravitreal Ranibizumab" @default.
- Q74279997 type Item @default.
- Q74279997 label "This Study Will Evaluate the Efficacy, Safety, and Pharmacokinetics of the Port Delivery System With Ranibizumab (PDS) in Participants With Diabetic Macular Edema (DME) Compared With Intravitreal Ranibizumab" @default.
- Q74279997 label "This Study Will Evaluate the Efficacy, Safety, and Pharmacokinetics of the Port Delivery System With Ranibizumab (PDS) in Participants With Diabetic Macular Edema (DME) Compared With Intravitreal Ranibizumab" @default.
- Q74279997 prefLabel "This Study Will Evaluate the Efficacy, Safety, and Pharmacokinetics of the Port Delivery System With Ranibizumab (PDS) in Participants With Diabetic Macular Edema (DME) Compared With Intravitreal Ranibizumab" @default.
- Q74279997 prefLabel "This Study Will Evaluate the Efficacy, Safety, and Pharmacokinetics of the Port Delivery System With Ranibizumab (PDS) in Participants With Diabetic Macular Edema (DME) Compared With Intravitreal Ranibizumab" @default.
- Q74279997 P1132 Q74279997-8142ACEC-1B58-4DCD-8EC5-FB76108F0863 @default.
- Q74279997 P1476 Q74279997-CCC8E32B-72C0-4E9A-AECB-D589EA658F50 @default.
- Q74279997 P17 Q74279997-09CC4BBC-74F4-480F-82BC-05974BD56943 @default.
- Q74279997 P1813 Q74279997-EED39C67-05B8-473F-9807-A77599AA93CB @default.
- Q74279997 P2899 Q74279997-46EE1082-23FA-463B-A982-F321B1480476 @default.
- Q74279997 P3098 Q74279997-D8624454-17D9-408F-8964-43A1F2594DD3 @default.
- Q74279997 P31 Q74279997-9A16B40D-6102-48D0-BE44-8546991540C5 @default.
- Q74279997 P4844 Q74279997-D1F6CD5C-8FB4-43C5-9783-8BD1DB5BACC2 @default.
- Q74279997 P580 Q74279997-2EBFD788-5E49-4D35-8DFF-B87EDA74940F @default.
- Q74279997 P582 Q74279997-1408D428-5C04-4B2A-8B9F-D353D16CEF03 @default.
- Q74279997 P6099 Q74279997-5CF95891-C5E1-4F95-A84E-EC2B9A6A1C39 @default.
- Q74279997 P8363 Q74279997-6043BC4C-88DA-4A56-9141-E119AA5F5432 @default.
- Q74279997 P859 Q74279997-860A1FCE-2E3B-4006-87D5-2A9C55061FA9 @default.
- Q74279997 P1132 "+545" @default.
- Q74279997 P1476 "A Phase III, Multicenter, Randomized, Visual Assessor-Masked, Active-comparator Study of the Efficacy, Safety, and Pharmacokinetics of the Port Delivery System With Ranibizumab in Patients With Diabetic Macular Edema (Pagoda)" @default.
- Q74279997 P17 Q30 @default.
- Q74279997 P1813 "Pagoda" @default.
- Q74279997 P2899 "+18" @default.
- Q74279997 P3098 "NCT04108156" @default.
- Q74279997 P31 Q30612 @default.
- Q74279997 P4844 Q414270 @default.
- Q74279997 P580 "2019-09-30T00:00:00Z" @default.
- Q74279997 P582 "2021-10-31T00:00:00Z" @default.
- Q74279997 P6099 Q42824827 @default.
- Q74279997 P8363 Q78089383 @default.
- Q74279997 P859 Q212646 @default.